about
Galphao/i-stimulated proteosomal degradation of RGS20: a mechanism for temporal integration of Gs and Gi pathwaysModulation of rap activity by direct interaction of Galpha(o) with Rap1 GTPase-activating protein.Modes of interactions between signaling pathways.Signaling networks: the origins of cellular multitaskingCannabinoid receptor-induced neurite outgrowth is mediated by Rap1 activation through G(alpha)o/i-triggered proteasomal degradation of Rap1GAPII.Role of the Go/i signaling network in the regulation of neurite outgrowth.Hypothermia: comparing technology.Biomarkers and vasospasm after aneurysmal subarachnoid hemorrhage.Cerebral autoregulation and acute ischemic stroke.Acute treatment of blood pressure after ischemic stroke and intracerebral hemorrhage.The Role of Statin Therapy in Hemorrhagic Stroke.Development of a neuro early mobilization protocol for use in a neuroscience intensive care unit.Vancomycin Pharmacokinetic Parameters in Patients with Hemorrhagic Stroke.Vancomycin pharmacokinetic parameters in patients with acute brain injury undergoing controlled normothermia, therapeutic hypothermia, or pentobarbital infusion.Influence of Single-Dose Antibiotic Prophylaxis for Early-Onset Pneumonia in High-Risk Intubated Patients.Adult neurogenesis as a potential therapy for neurodegenerative diseases.Neoplastic Cerebral Aneurysm From Metastatic Nonsmall Cell Lung Carcinoma: Case Report and Literature Review.Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational studyThe Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain InjuryEnhanced renal clearance and impact on vancomycin pharmacokinetic parameters in patients with hemorrhagic strokeStroke in Patients With Peripheral Artery DiseaseEnhanced Renal Clearance in Patients With Hemorrhagic Stroke
P50
Q24626665-2F423A0F-617B-47D7-B3A6-3A3C65CF9551Q30741758-72CFC811-AA52-4449-9512-7C880ECE946DQ33541044-4CDE3C5F-0555-49E2-A49D-EBC95F0384F1Q33923713-2CAD95E9-4C98-4DFA-850E-7A773EA39781Q34385582-70F4FE7B-EFE0-47E0-A596-C1A1AF272DCCQ36602612-94967EE7-59A0-4D86-A4C1-D99AF350FDBDQ36833179-EC455775-4F4C-4AB6-A46D-64F861FAFF22Q37728220-FDC63D6A-25D9-407D-8E49-C17023CF1418Q38008914-C2A317A4-D36A-45D1-806E-D5C6B0D8403EQ38439827-4C2315E8-1EC4-4E69-92A4-5D1EA954054AQ38673887-B56D0911-0FAF-4E0E-A6A1-5BCC1D374AC0Q38689272-15180508-3F4F-4096-81A6-7FBBE3383D8CQ39948315-328F08BA-8932-44DE-A5AD-9F06F0B89707Q43635861-841ED9CF-3905-4F62-86A6-4FF3B0FA7F9AQ47177969-78F246E6-8DD6-429E-92E4-E3C1867EA71AQ51082922-14F30F98-C76B-48EF-99EC-61294352EF00Q52732392-1C225811-876D-4B33-8468-0D7FAA1E8E4EQ56333846-C57BDA6A-2199-4926-B80E-D3991646804AQ90549165-FEBD266A-87A5-4902-80FF-0FE20B3AF60EQ91937455-58FE21D6-5043-4C27-A85F-B77B27BC7866Q92046592-7E9B2C91-1615-42D0-9DCA-23F2C49A05EEQ92356565-67975C63-065E-4089-82CA-84E239887833
P50
description
researcher
@en
name
J D Jordan
@en
J D Jordan
@nl
type
label
J D Jordan
@en
J D Jordan
@nl
prefLabel
J D Jordan
@en
J D Jordan
@nl
P106
P31
P496
0000-0002-0706-9583